"Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?" by Irene Giacomelli

Article

Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?

Journal of gastrointestinal oncology (2017)

Irene Giacomelli, Proton Treatment Center, APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Daniele Scartoni, Proton Treatment Center, APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Homan Mohammadi, University of Maryland, Baltimore
William F. Regine, University of Maryland, Baltimore
Michael D. Chuong, Baptist Hospital of Miami

Link

Disciplines

Publication Date

August 1, 2017

DOI

10.21037/JGO.2017.06.14

Citation Information

Irene Giacomelli, Daniele Scartoni, Homan Mohammadi, William F. Regine, et al.. "Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?" Journal of gastrointestinal oncology Vol. 8 Iss. 4 (2017) p. 721 - 727
Available at: http://works.bepress.com/michael-chuong/138/